# A Study Called GUS to Understand How Much of the Contrast Agent Gadavist is Used and How Much is Wasted in Two Different Containers (Single-dose Vials and Imaging Bulk Packages ) in a Real-world Setting

> **NCT05350189** · — · COMPLETED · sponsor: **Bayer** · enrollment: 1602 (actual)

## Conditions studied

- Contrast Enhancement in Magnetic Resonance Imaging

## Interventions

- **DRUG:** Gadobutrol (Gadavist/Gadovist, BAY86-4875)

## Key facts

- **NCT ID:** NCT05350189
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-03
- **Primary completion:** 2023-03-28
- **Final completion:** 2023-04-27
- **Target enrollment:** 1602 (ACTUAL)
- **Last updated:** 2024-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05350189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05350189, "A Study Called GUS to Understand How Much of the Contrast Agent Gadavist is Used and How Much is Wasted in Two Different Containers (Single-dose Vials and Imaging Bulk Packages ) in a Real-world Setting". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05350189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*